Mach7 signs Temple Health to 5-year eUnity and VNA subscription licence
Mach7 Technologies (ASX: M7T) announced on 13 November 2026 that Temple Health has signed a 5-year subscription licence for the eUnity Viewer and Vendor Neutral Archive (VNA). The contract is effective 30 October 2026.
Subscription wins of this kind matter because Mach7’s FY26 results showed recurring revenue at 84% of total, with management naming new customer wins as one of four metrics for FY27.
Key terms of the contract include:
- Term: 5 years, covering the eUnity Viewer and VNA
- Effective date: 30 October 2026
- Year 1 ARR: Annual Recurring Revenue (ARR) of A$0.5M is expected following go-live
- Exchange rate assumption: the ARR figure assumes an AUD/USD exchange rate of $0.68
Teri Thomas, CEO and Managing Director
“This partnership continues to strengthen Mach7’s presence in academic health systems and integrated delivery networks, reflecting our focus on growing the business by solving practical challenges for clinicians and supporting better care for the people they serve.”
When big ASX news breaks, our subscribers know first
Temple Health: an academic health system across Philadelphia
Temple Health is a Philadelphia-based academic health system, making it a large, multi-campus customer for eUnity and the VNA. According to the announcement, it has:
- 990 licensed beds
- More than 1,700 physicians
- More than 350 researchers
Its network includes the main campus of Temple University Hospital in North Philadelphia, the Jeanes, Episcopal and Northeastern campuses, Temple Health-Chestnut Hill Hospital, and Fox Chase Cancer Centre, an NCI-designated comprehensive cancer centre.
Recognised programs span organ transplantation, lung and thoracic medicine, cardiovascular medicine, neurosciences, orthopaedics and sports medicine, gastroenterology, oncology and urology.
Thomas said that “for patients whose care involves multiple teams, connected imaging can support more informed decisions and better coordinated care.”
What happens next for Mach7 and Temple Health
- First Productive Use (FPU) is expected within 6-12 months, according to the announcement.
- The Year 1 ARR contribution is expected following go-live.
Mach7’s earlier AMRADNET eUnity contract set a much shorter benchmark, targeting first productive use within 45 days after the company restructured its sales and services teams.
Want Alerts Like This on the Healthcare Stocks You Follow?
StockWire X Market Intelligence scores every announcement in our coverage for how significant it’s likely to be for investors, and which way it points, then alerts you on the stocks you follow. The first 1,000 founding members lock in 50% off for life: A$247 a year instead of the standard A$495. Join the founding waitlist to claim your spot.